Search clinical trials for: UCB4940
Total 42 results
-
UCB CelltechParexel; Comac Medical; MAC Clinical Research; ARENSIA, MoldovaCompletedPsoriatic ArthritisBulgaria, Moldova, Republic of, United Kingdom
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, Germany, Hungary, Italy, Japan, Korea, Republic of, Poland, Russian Federation, Taiwan, United Kingdom
-
UCB Biopharma SRLCompletedPsoriatic ArthritisUnited States, Czechia, Germany, Hungary, Poland, Russian Federation
-
UCB Biopharma S.P.R.L.CompletedHealthy VolunteersUnited States, Germany
-
UCB Biopharma SRLCompletedAnkylosing SpondylitisUnited States, Bulgaria, Canada, Czechia, Germany, Hungary, Poland, Russian Federation, Spain, Ukraine
-
UCB Biopharma SRLCompletedChronic Plaque PsoriasisUnited States, Australia, Canada, Moldova, Republic of
-
UCB Biopharma SRLActive, not recruitingHidradenitis SuppurativaUnited States, Australia, Belgium, Bulgaria, Canada, Czechia, France, Germany, Greece, Hungary, Ireland, Italy, Japan, Netherlands, Poland, Spain, Switzerland, Turkey, United Kingdom
-
UCB Biopharma SRLCompletedHidradenitis SuppurativaUnited States, Australia, Bulgaria, Canada, Czechia, France, Germany, Hungary, Ireland, Israel, Japan, Poland, Spain, United Kingdom
-
UCB Biopharma SRLActive, not recruitingAnkylosing Spondylitis | Axial Spondyloarthritis | r-axSpa | Nr-axSpaUnited States, Belgium, Bulgaria, China, Czechia, France, Germany, Hungary, Japan, Netherlands, Poland, Spain, Turkey, United Kingdom
-
UCB Biopharma S.P.R.L.CompletedPsoriatic ArthritisUnited States, Czechia, Germany, Hungary, Poland, Russian Federation
-
UCB Biopharma SRLTerminatedHealthy Study ParticipantsGermany
-
UCB Biopharma SRLActive, not recruitingPsoriatic ArthritisUnited States, Australia, Belgium, Canada, Czechia, France, Germany, Hungary, Italy, Japan, Poland, Russian Federation, Spain, United Kingdom
-
UCB Biopharma SRLActive, not recruitingModerate to Severe Plaque PsoriasisUnited States, Canada, Germany, Poland
-
UCB Biopharma SRLCompletedHealthy Study ParticipantsUnited States, Germany
-
UCB Biopharma S.P.R.L.CompletedAnkylosing SpondylitisUnited States, Bulgaria, Canada, Czechia, Germany, Hungary, Poland, Russian Federation, Spain, Ukraine
-
UCB Biopharma SRLParexelCompletedChronic Plaque PsoriasisUnited States, Australia, Canada, Moldova, Republic of
-
UCB Biopharma SRLCompletedChronic Plaque PsoriasisUnited States, Canada, Czechia, Hungary, Japan, Poland
-
UCB CelltechCompletedA Study to Evaluate the Relative Bioavailability and Tolerability of Bimekizumab in Healthy SubjectsHealthy VolunteersUnited Kingdom
-
UCB Biopharma SRLCompletedPsoriatic ArthritisUnited States, Australia, Canada, Czechia, Germany, Hungary, Italy, Japan, Poland, Russian Federation, United Kingdom
-
UCB Biopharma SRLCompletedNonradiographic Axial SpondyloarthritisUnited States, Belgium, Bulgaria, China, Czechia, France, Germany, Hungary, Japan, Poland, Spain, Turkey, United Kingdom
-
UCB Biopharma SRLCompletedHidradenitis SuppurativaUnited States, Australia, Belgium, Canada, Denmark, France, Germany, Greece, Israel, Italy, Netherlands, Norway, Spain, Switzerland, Turkey
-
UCB Biopharma SRLCompletedModerate to Severe Plaque PsoriasisKorea, Republic of
-
UCB Biopharma SRLCompletedAnkylosing SpondylitisUnited States, Belgium, Bulgaria, China, Czechia, France, Germany, Hungary, Japan, Netherlands, Poland, Spain, Turkey, United Kingdom
-
UCB CelltechCompletedMild to Moderate PsoriasisUnited Kingdom
-
UCB Biopharma S.P.R.L.CompletedHealthy VolunteersUnited States
-
UCB Biopharma SRLCompletedPsoriatic ArthritisUnited States, Czechia, Germany, Hungary, Poland, Russian Federation
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Canada
-
UCB Biopharma S.P.R.L.ParexelCompletedChronic Plaque PsoriasisUnited States, Canada, Czechia, Hungary, Japan, Poland
-
UCB Biopharma SRLTerminatedAn Open-label Extension Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal EpilepsyHighly Drug-resistant Focal EpilepsyBelgium, Bulgaria, Germany, Hungary, Netherlands, Spain
-
UCB Biopharma S.P.R.L.PRA Health SciencesCompletedHighly Drug-resistant Focal EpilepsyBelgium, Bulgaria, Germany, Hungary, Netherlands, Spain
-
UCB Biopharma SRLCompletedPsoriatic Arthritis | Moderate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, United Kingdom
-
UCB Biopharma S.P.R.L.CompletedHealthy Japanese and Caucasian SubjectsUnited Kingdom
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, France, Germany, Netherlands, Poland, Spain, Turkey, United Kingdom
-
UCB Biopharma SRLCompletedHidradenitis SuppurativaUnited States, Australia, Belgium, Denmark, Germany, Greece, Norway, Russian Federation
-
UCB Biopharma S.P.R.L.TerminatedImpaired Hepatic Function | Healthy Study ParticipantsUnited States
-
UCB Biopharma SRLCompletedPsoriatic Arthritis | Moderate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, Germany, Hungary, Italy, Japan, Poland, Russian Federation, United Kingdom
-
UCB Biopharma SRLCompletedModerate to Severe Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, Taiwan
-
UCB Biopharma SRLCompletedPsoriatic ArthritisUnited States, Australia, Belgium, Canada, Czechia, France, Germany, Hungary, Italy, Japan, Poland, Russian Federation, Spain, United Kingdom
-
UCB Biopharma SRLCompletedAnkylosing SpondylitisUnited States, Czechia, Germany, Greece, Moldova, Republic of, Netherlands, Poland, Russian Federation
-
UCB Biopharma S.P.R.L.CompletedPharmacokineticsUnited Kingdom
-
SunovionCompletedExercise-induced BronchospasmUnited States
-
UCB Biopharma S.P.R.L.Completed